Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitja Jevnikar

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Circulation|October 27, 2017
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial HypertensionJason Weatherald, Athénaïs Boucly, Denis Chemla, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2022
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantationHugues Vicaire, Jérôme Le Pavec, Olaf Mercier, et al.
The European Respiratory Journal|December 22, 2022
Cytokines as prognostic biomarkers in pulmonary arterial hypertensionAthénaïs Boucly, Ly Tu, Christophe Guignabert, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
ERJ Open Research|January 16, 2024
Outcomes and risk assessment in pulmonary veno-occlusive diseaseAthénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
The European Respiratory Journal|April 25, 2024
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertensionAthénaïs Boucly, Antoine Beurnier, Ségolène Turquier, et al.
Chest|July 26, 2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersChristian Gerges, Antoine Beurnier, Xavier Jaïs, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 5, 2021
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registryAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Frontiers in Medicine|March 24, 2022
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?Romain Le Pennec, Cécile Tromeur, Charles Orione, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Circulation|October 27, 2017
Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial HypertensionJason Weatherald, Athénaïs Boucly, Denis Chemla, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2022
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantationHugues Vicaire, Jérôme Le Pavec, Olaf Mercier, et al.
The European Respiratory Journal|December 22, 2022
Cytokines as prognostic biomarkers in pulmonary arterial hypertensionAthénaïs Boucly, Ly Tu, Christophe Guignabert, et al.
The European Respiratory Journal|August 5, 2017
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertensionAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
ERJ Open Research|January 16, 2024
Outcomes and risk assessment in pulmonary veno-occlusive diseaseAthénaïs Boucly, Sabina Solinas, Antoine Beurnier, et al.
The European Respiratory Journal|April 25, 2024
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertensionAthénaïs Boucly, Antoine Beurnier, Ségolène Turquier, et al.
Chest|July 26, 2024
Role of Exercise Hemodynamics in the Prediction of Pulmonary Arterial Hypertension in BMPR2 Mutation CarriersChristian Gerges, Antoine Beurnier, Xavier Jaïs, et al.
The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.
The European Respiratory Journal|November 5, 2021
External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registryAthénaïs Boucly, Jason Weatherald, Laurent Savale, et al.
Frontiers in Medicine|March 24, 2022
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?Romain Le Pennec, Cécile Tromeur, Charles Orione, et al.
Pageof 6